STOCKHOLM, July 29, 2022 /PRNewswire/ -- During July,
Calliditas Therapeutics AB (publ) has issued 51,399 ordinary shares
as part of the company's long-term incentive program for certain
members of the board of directors issued in 2019, Board LTIP 2019,
and converted 5,908,018 class C-shares to 5,908,018 ordinary shares
as part of the establishment of the company's at-the-market
program. Thus, as of July 29, 2022,
the number of shares and votes in the company amounts to 59,157,587
shares and 59,157,587 votes.
For further information, please contact:
Mikael Widell, Investor relations
Tel.: +46 703 11 99 60, email:
mikael.widell@calliditas.com
The information in the press release is such that Calliditas
Therapeutics AB (publ) is required to disclose pursuant to the
Swedish Financial Instruments Trading Act. The information was
submitted for publication, through the agency of the contact
persons set out above, at 12:00 CEST
on July 29, 2022.
About Calliditas
Calliditas Therapeutics is a commercial stage biopharma company
based in Stockholm, Sweden focused
on identifying, developing and commercializing novel treatments in
orphan indications, with an initial focus on renal and hepatic
diseases with significant unmet medical needs.
Calliditas' lead product, developed under the name Nefecon, has
been granted accelerated approval by the FDA under the trade name
TARPEYO™ and conditional marketing authorization by the
European Commission under the trade name KINPEYGO®. Additionally,
Calliditas is conducting a Phase 2b/3
clinical trial in primary biliary cholangitis and a Phase 2
proof-of-concept trial in head and neck cancer with its NOX
inhibitor product candidate, setanaxib. Calliditas' common shares
are listed on Nasdaq Stockholm (ticker: CALTX) and its American
Depositary Shares are listed on the Nasdaq Global Select Market
(ticker: CALT).
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/number-of-shares-and-votes-in-calliditas-therapeutics,c3608053
The following files are available for download:
|
https://mb.cision.com/Main/16574/3608053/1610015.pdf
|
Number of shares and
votes July 2022 (Eng)
|